Results 241 to 250 of about 213,470 (338)

The requirement of guanine nucleotides for glucagon stimulation of adenylate cyclase in rat liver plasma membranes.

, 1977
Narimichi Kimura, N NAGATA
openalex   +1 more source

Erythematous Papules and Plaques in an Infant Receiving Glucagon Therapy

JEADV Clinical Practice, EarlyView.
Sara Al Janahi, Alya Al‐Ali, Meera Al Adawi, Yusra S. Al Ali, Harish Bangalore   +4 more
wiley   +1 more source

A geriatrician's approach to managing the complex older adult with obesity

Obesity, EarlyView.
Abstract The prevalence of obesity in older adults is rapidly increasing due to the demographic shift occurring globally. Older adults with obesity face health care challenges due to multimorbidity, functional dependency, and disability. This population often has prior history of struggles through weight‐loss attempts during the middle years of life ...
Shenbagam Dewar
wiley   +1 more source

CK2 regulates somatostatin expression in pancreatic delta cells. [PDF]

Islets
Wrublewsky S, Clemenz A, Boewe AS, Wilden C, Bickelmann C, Götz C, MacDonald PE, Laschke MW, Ampofo E.   +8 more
europepmc   +1 more source

Induction of tyrosine aminotransferase synthesis in isolated liver cell suspensions. Absolute dependence of induction on glucocorticoids and glucagon or cyclic AMP.

, 1977
Michael J. Ernest, Chien‐Liang Chen, Philip Feigelson   +2 more
openalex   +1 more source

Long‐acting PYY3−36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies

Obesity, EarlyView.
Abstract Objective The hormone peptide YY (PYY; cleaved into Y2‐selective form PYY3‐36) is an attractive candidate for use as a complementary pharmacotherapy for obesity along with glucagon‐like peptide‐1 (GLP‐1) receptor agonists. This series of studies investigated a novel long‐acting PYY3‐36 analogue (PYY1875) alone and as an add‐on to semaglutide ...
Birgitte S. Wulff, Adam Paul Chambers, Cynthia Karenina Osorto Contreras, Katrine Kirkeby, Anders Rasmussen Rinnov, Riia K. Sustarsic, Søren Østergaard, John E. Laabs, Patrick M. O'Neil   +8 more
wiley   +1 more source

β-Cells: So Sensitive. [PDF]

Diabetes
Norris N, Kebede MA, Laybutt DR, Gunton JE.   +3 more
europepmc   +1 more source

Effects of estrogen, glucocorticoid, glucagon, and adenosine 3':5'-monophosphate on catalytic activity, amount, and rate of de novo synthesis of hepatic histidase.

, 1977
Coral A. Lamartiniere, Muriel Feigelson
openalex   +1 more source

Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status

Obesity, EarlyView.
Abstract Objective The objective of this study was to characterize changes in body weight and glycated hemoglobin (in those with prediabetes at baseline) through 12 months by obesity pharmacotherapy discontinuation status. Methods This retrospective cohort study used electronic health record data from a large health system in Ohio and Florida to ...
Hamlet Gasoyan, W. Scott Butsch, Rebecca Schulte, Nicholas J. Casacchia, Phuc Le, Christopher B. Boyer, Marcio L. Griebeler, Bartolome Burguera, Michael B. Rothberg   +8 more
wiley   +1 more source

Glucagon-stimulated phosphorylation of pyruvate kinase in hepatocytes.

, 1978
Hiromi Ishibashi, G.Larry Cottam
openalex   +1 more source